Clinical Trials Logo
  1. Home
  2. Placenta Previa
  3. NCT03060889
  4. Details
NCT03060889 Clinical Trial

Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa

Placenta Previa Clinical Trial

Official title:
Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa: A Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03060889
Other study ID # AAbdelaziz
Secondary ID
Status Completed
Phase Phase 3
First received January 10, 2017
Last updated February 21, 2017
Start date February 2016
Est. completion date December 2016

Study information
Verified date February 2017
Source Ain Shams University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa

Description:

Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa to detect efficacy of Tranexamic acid in decreasing blood loss

Recruitment information / eligibility
Status Completed
Enrollment 86
Est. completion date December 2016
Est. primary completion date November 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- Term pregnancy (more than 37 weeks of gestation)

- Diagnosis of placenta previa was confirmed by ultrasound

- The patient hemoglobin percentage is more than 10 mg/dl

Exclusion Criteria:

- Invading placenta previa diagnosis was confirmed by Doppler ultrasound studies

- Emergency lower segment cesarean section

- Associated medical comorbidities

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Tranexamic acid
10 mg/kg body weight will be given with induction of anesthesia by intravenous infusion

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Ain Shams University

Outcome
Type Measure Description Time frame Safety issue
Primary intra operative blood loss in ml Calculation of blood loss during cesarean section in the two groups to detect efficacy of Tranexamic acid in reducing blood loss intraoperative during cesarean section
See also
  Status Clinical Trial Phase
Recruiting NCT04518163 - Bakri Balloon Plus Tranexamic Acid During Cesarean Delivery for Placenta Previa N/A
Recruiting NCT04518150 - Combined Bilateral Uterine Artery Ligation and Bakri Balloon During Cesarean Section N/A
Recruiting NCT03638024 - Cell-free Fetal DNA Concentration in Cases of Abnormal Placental Invasion .
Terminated NCT01996345 - Vaginal Pessary Versus Expectant Management for Placenta Previa N/A
Recruiting NCT04609527 - Management of Placenta Accreta Spectrum Phase 2/Phase 3
Completed NCT03431116 - Low Implanted Second Trimester Placenta and Placenta Previa N/A
Completed NCT03321435 - The Placenta Previa and Fetal Weight N/A
Enrolling by invitation NCT05529381 - Anxiety and Depressive Symptoms in Placenta Previa / Accreta
Completed NCT04264234 - Management Of Placenta Previa Cases And Determination Of Hospitalization Criteria N/A
Completed NCT05340205 - Blood Loss During Cesarean Delivery in Placenta Previa Patients Phase 4
Completed NCT03570723 - Glove-loaded Foley's Catheter Tamponade for Cesarean Section for Placenta Previa N/A
Completed NCT05283122 - Mostafa Maged Technique to Control and Prevent the Post-Partum Bleeding From the Lower Uterine Segment in Placenta Previa Cases N/A
Withdrawn NCT01442207 - Cerclage for Prevention on Preterm Birth in Women With Placenta Previa Phase 3
Not yet recruiting NCT03451136 - Cervical Length in Cases of Placenta Previa N/A
Completed NCT02966197 - Efficacy of Prophylactic Internal Iliac Artery Balloon Catheterization in the Management of Placenta Previa and Accreta N/A
Recruiting NCT02590484 - The Cervix as a Natural Tamponade in Postpartum Hemorrhage Caused by Placenta Previa and Placenta Previa Accreta N/A
Recruiting NCT05802251 - Sonographic Parameters and Risk of Antepartum Hemorrhage in Asymptomatic Women With Placenta Previa: A Cohort Study
Completed NCT03542552 - Nifedipine Versus Magnesium Sulfate for Prevention of Preterm Labor in Symptomatic Placenta Previa Phase 3
Recruiting NCT03124472 - Effect of Uterine Artery Ligation Prior to Uterine Incision in Women With Placenta Previa N/A
Recruiting NCT03633175 - Progesterone in Patients With Placenta Previa Phase 2